These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11427987)

  • 41. The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4.
    García-Santos EP; Padilla-Valverde D; Villarejo-Campos P; Murillo-Lázaro C; Fernández-Grande E; Palomino-Muñoz T; Rodríguez-Martínez M; Amo-Salas M; Nuñez-Guerrero P; Sánchez-García S; Puerto-Puerto A; Martín-Fernández J
    Pancreatology; 2016; 16(4):632-9. PubMed ID: 27289344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells.
    Clarke WR; Amundadottir L; James MA
    Int J Cancer; 2019 Mar; 144(6):1367-1378. PubMed ID: 30468251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients.
    Yanagimoto H; Shiomi H; Satoi S; Mine T; Toyokawa H; Yamamoto T; Tani T; Yamada A; Kwon AH; Komatsu N; Itoh K; Noguchi M
    Oncol Rep; 2010 Sep; 24(3):795-801. PubMed ID: 20664989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Troxacitabine prodrugs for pancreatic cancer.
    Adema AD; Radi M; Daft J; Narayanasamy J; Hoebe EK; Alexander LE; Chu CK; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1073-7. PubMed ID: 18058539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pancreatic cancer: is this bleak landscape finally changing? Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June 1-5, 2007.
    Saif MW
    JOP; 2007 Jul; 8(4):365-73. PubMed ID: 17625289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel therapies for pancreatic adenocarcinoma.
    Pino SM; Xiong HQ; McConkey D; Abbruzzese JL
    Curr Gastroenterol Rep; 2004 Apr; 6(2):119-25. PubMed ID: 15191689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer.
    Kaida M; Morita-Hoshi Y; Soeda A; Wakeda T; Yamaki Y; Kojima Y; Ueno H; Kondo S; Morizane C; Ikeda M; Okusaka T; Takaue Y; Heike Y
    J Immunother; 2011 Jan; 34(1):92-9. PubMed ID: 21150717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives.
    Hosseini M; Hassanian SM; Mohammadzadeh E; ShahidSales S; Maftouh M; Fayazbakhsh H; Khazaei M; Avan A
    J Cell Biochem; 2017 Jul; 118(7):1634-1638. PubMed ID: 28106283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Salvage chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer: survival benefit in selected patients].
    Lee JL; Kim YT
    Korean J Gastroenterol; 2008 Jul; 52(1):59-63. PubMed ID: 19077495
    [No Abstract]   [Full Text] [Related]  

  • 50. Advanced pancreatic cancer: is there a role for combination therapy?
    Kulke MH
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):729-39. PubMed ID: 14599095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monogalactosyl diacylglycerol, a replicative DNA polymerase inhibitor, from spinach enhances the anti-cell proliferation effect of gemcitabine in human pancreatic cancer cells.
    Akasaka H; Sasaki R; Yoshida K; Takayama I; Yamaguchi T; Yoshida H; Mizushina Y
    Biochim Biophys Acta; 2013 Mar; 1830(3):2517-25. PubMed ID: 23174220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients.
    Miyazawa M; Katsuda M; Maguchi H; Katanuma A; Ishii H; Ozaka M; Yamao K; Imaoka H; Kawai M; Hirono S; Okada KI; Yamaue H
    Int J Cancer; 2017 Feb; 140(4):973-982. PubMed ID: 27861852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Options for the treatment of gemcitabine-resistant advanced pancreatic cancer.
    Gounaris I; Zaki K; Corrie P
    JOP; 2010 Mar; 11(2):113-23. PubMed ID: 20208317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy: results of a phase I/II clinical trial.
    Salmons B; Löhr M; Günzburg WH
    J Gastroenterol; 2003 Mar; 38 Suppl 15():78-84. PubMed ID: 12698877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metastatic pancreatic cancer 2008: is the glass less empty?
    Nieto J; Grossbard ML; Kozuch P
    Oncologist; 2008 May; 13(5):562-76. PubMed ID: 18515741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The role of membrane transporters in cellular resistance of pancreatic carcinoma to gemcitabine].
    Mohelníková-Duchonová B; Soucek P
    Klin Onkol; 2010; 23(5):306-10. PubMed ID: 21061681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.
    Bramhall SR; Schulz J; Nemunaitis J; Brown PD; Baillet M; Buckels JA
    Br J Cancer; 2002 Jul; 87(2):161-7. PubMed ID: 12107836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].
    Krempien R; Muenter MW; Huber PE; Nill S; Friess H; Timke C; Didinger B; Buechler P; Heeger S; Herfarth KK; Abdollahi A; Buchler MW; Debus J
    BMC Cancer; 2005 Oct; 5():131. PubMed ID: 16219105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting signal transduction in pancreatic cancer treatment.
    Yeh JJ; Der CJ
    Expert Opin Ther Targets; 2007 May; 11(5):673-94. PubMed ID: 17465725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
    Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
    Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.